Common acquired causes of thrombosis in children

Current Problems in Pediatric and Adolescent Health Care

Volumn 43, Issue 7, 2013, Pages 169-177

  Tolbert, Jaszianne ^a   Carpenter, Shannon L ^a  

^a CHILDREN S MERCY HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ASPARAGINASE; BLOOD CLOTTING FACTOR 8; HEPARIN; LIPOCORTIN 5; PHOSPHATIDYLETHANOLAMINE; PHOSPHATIDYLINOSITOL; PHOSPHATIDYLSERINE; PHOSPHOLIPID ANTIBODY; PLASMINOGEN ACTIVATOR INHIBITOR 1; PREDNISOLONE; PREDNISONE; PROTEIN C; PROTEIN S; PROTHROMBIN; RETINOL; THROMBIN; THROMBOPLASTIN; VON WILLEBRAND FACTOR; WARFARIN;

ACUTE LYMPHOBLASTIC LEUKEMIA; ACUTE MYELOBLASTIC LEUKEMIA; ANTICOAGULANT THERAPY; ANTIPHOSPHOLIPID SYNDROME; ARTERIAL BLOOD; ARTERIAL THROMBOEMBOLISM; ARTERY THROMBOSIS; ARTICLE; BRAIN ISCHEMIA; CHILDHOOD CANCER; CONGENITAL HEART DISEASE; DEEP VEIN THROMBOSIS; EWING SARCOMA; FALLOT TETRALOGY; FIBRINOLYTIC THERAPY; FONTAN PROCEDURE; GENE MUTATION; GENETIC VARIABILITY; GLENN SHUNT; HEART CATHETERIZATION; HEART SINGLE VENTRICLE; HUMAN; INDWELLING CATHETER; INTRAVENOUS CATHETER; LEUKOPENIA; LIVEDO RETICULARIS; LOW DRUG DOSE; LUNG EMBOLISM; MORBIDITY; NEPHROBLASTOMA; NEUROBLASTOMA; OXYGEN SATURATION; PULMONARY VALVE ATRESIA; RHABDOMYOSARCOMA; RISK FACTOR; SURVIVAL RATE; THROMBOCYTOPENIA; THROMBOPHILIA; THROMBOSIS; TRICUSPID VALVE ATRESIA;

EID: 84880888247     PISSN: 15385442     EISSN: 15383199     Source Type: Journal    
DOI: 10.1016/j.cppeds.2013.05.005     Document Type: Review

References (83)

1. M. Andrew, M. David, and M. Adams Venous thromboembolic complications (VTE) in children: first analyses of the Canadian Registry of VTE Blood 83 5 1994 1251 1257
2. B. Schmidt, and M. Andrew Neonatal thrombosis: report of a prospective Canadian and international registry Pediatrics 96 5 Pt 1 1995 939 943
3. C.H. van Ommen, H. Heijboer, and H.R. Buller Venous thromboembolism in childhood: a prospective two-year registry in The Netherlands J Pediatr 139 5 2001 676 681
4. B.E.S. Gibson, E.A. Chalmers, and P. Bolton-Maggs Thromboembolism in childhood: a prospective two year BPSU study in the United Kingdom. February 2001-February 2003 Thromb Haemost 1 suppl 1 2003 [OC422]
5. P.D. Stein, F. Kayali, and R.E. Olson Incidence of venous thromboembolism in infants and children: data from the National Hospital Discharge Survey J Pediatr 145 2004 563 565
6. J.R. Boris, and M.A. Harris The use of anticoagulation in pediatric cardiac disease Images Pediatr Cardiol 16 2003 1 35
7. J.I. Hoffman, and S. Kaplan The incidence of congenital heart disease J Am Coll Cardiol 39 12 2002 1890 1900
8. L.C. Jordan Stroke in childhood Neurologist 12 2006 94 102
9. P. Monagle, M. Adams, and M. Mahoney Outcome of paediatric thromboembolic disease: a report from the Canadian childhood thrombosis registry Pediatr Res 47 2000 763 766
10. M. Gillespie, M. Kuijpers, and M. Van Rossem Determinants of intensive care unit length of stay for infants undergoing cardiac surgery Congenit Heart Dis 1 2006 152 160
11. P. Monagle Thrombosis in children with BT shunts, Glenns and Fontans Prog Pediatr Cardiol 21 2005 17 21
12. D. Bennet, R. Marcus, and M. Stokes Incidents and complications during pediatric cardiac catheterization Paediatr Anaesth 15 12 2005 Dec 1083 1088
13. D.E. Miga, L.F. McKellar, and S. Denslow Incidence of femoral vein occlusion after catheter ablation in children: evaluation with magnetic resonance angiography Pediatr Cardiol 18 3 1997 204 207
14. Z.R. Bulbul, M.O. Galal, and E. Mahmoud Arterial complications following cardiac catheterization in children less than 10 kg Asian Cardiovasc Thorac Ann 10 2 2002 129 132
15. S. Laurin, and N.R. Lundström Venous thrombosis after cardiac catheterization in infants Acta Radiol 28 3 1987 241 246
16. C. Smith, and R.M. Green Pediatric vascular injuries Surgery 90 1981 20 31
17. W. Mortensson, T. Hallbook, and N.R. Lundstrom Percutaneous catheterization of the femoral vessels in children II. Thrombotic occlusion of the catheterized artery: frequency and causes Pediatr Radiol 4 1975 1 9
18. M.D. Freed, J.F. Keane, and A. Rosenthal The use of heparinization to prevent arterial thrombosis after percutaneous cardiac catheterization in children Circulation 50 1974 565 569
19. P. Barach, J.K. Johnson, and A. Ahmad A prospective observational study of human factors, adverse events, and patient outcomes in surgery for pediatric cardiac disease J Thorac Cardiovasc Surg 136 6 2008 1422 1428
20. A. Blalock Physiopathology and surgical treatment of congenital cardiovascular defects Harvey Lect 1945-1946 90 116 41 1945-1946 90 116
21. W. Glenn Circulatory bypass of the right side of the heart. IV. Shunt between superior vena cava and distal right pulmonary artery; report of clinical application N Engl J Med 259 3 1958 117 120
22. F. Fontan, and E. Baudet Surgical repair of tricuspid atresia Thorax 26 3 1971 240 248
23. K.T. Tsai, C.H. Chang, and P.J. Lin Modified Blalock-Taussig shunt: statistical analysis of potential factors influencing shunt outcome J Cardiovasc Surg (Torino) 37 1996 149 152
24. G. Gladman, B.W. McCrindle, and W.G. Williams The modified Blalock-Taussig shunt: clinical impact and morbidity in Fallot's tetralogy in the current era J Thorac Cardiovasc Surg 114 1997 25 30
25. E.M. Zahn, A.C. Chang, and A. Aldousany Emergent stent placement for acute Blalock-Taussig shunt obstruction after stage 1 Norwood surgery Cathet Cardiovasc Diagn 42 1997 191 194
26. J. Klinge, M. Hofbeck, and M. Ries Thrombolysis of modified Blalock-Taussig shunts in childhood with recombinant tissue type plasminogen activator Z Kardiol 84 1995 476 480
27. Z.M. Hijazi Stenting for postoperative congenital heart disease in infants Cathet Cardiovasc Diagn 42 1997 195 198
28. J.S. Li, E. Yow, and K.Y. Berezny Clinical outcomes of palliative surgery including a systemic-to-pulmonary artery shunt in infants with cyanotic congenital heart disease: does aspirin make a difference? Circulation 116 3 2007 293 297
29. P. Monagle, A.K. Chan, and N.A. Goldenberg American College of Chest Physicians. Antithrombotic therapy in neonates and children: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (9th ed.) Chest 141 2 suppl. 2012 e737S e7801
30. M.L. Jacobs, and G. Pelletier Late complications associated with the Fontan circulation Cardiol Young 16 suppl. 1 2006 80 84
31. P. Monagle, A. Cochrane, and R. Roberts A multicentre randomized trial comparing heparin/warfarin and aspirin as primary thromboprophylaxis for two years after fontan procedure in children J Am Coll Cardiol 58 2011 645 651
32. J.H. Payne, and A.J. Vora Thrombosis and acute lymphoblastic leukaemia Br J Haematol 138 2007 430 445
33. D.E. Sutherland, I.C. Weitz, and H.A. Liebman Thromboembolic complications of cancer epidemiology, pathogenesis, diagnosis, and treatment Am J Hematol 72 2003 43 52
34. A. Falanga, and F.R. Rickles Pathophysiology of the thrombophilic state in the cancer patient Semin Thromb Hemost 25 1999 173 181
35. R.L. Bick Cancer-associated thrombosis N Engl J Med 349 2003 109 111
36. C. Male, P. Chait, and M. Andrew Central venous line-related thrombosis in children: association with central venous location and insertion technique Blood 101 2003 4273 4278
37. D.W. Glaser, D. Medeiros, and N. Rollins Catheter-related thrombosis in children with cancer J Pediatr 138 2 2001 255 259
38. B. Olas, B. Wachowicz, and W.P. Mielicki Cancer procoagulant and blood platelet activation Cancer Lett 169 2001 165 171
39. R.W. Bell The fibrinolytic system in neoplasia Semin Thromb Hemost 22 1996 459 478
40. T.C. Abshire, S.H. Gold, and L.F. Odom The coagulopathy of childhood leukemia Thrombin activation or primary fibrinolysis? Cancer 66 1990 716 721
41. H.C. Kwaan The plasminogen-plasmin system in malignancy Cancer Metastasis Rev 11 1992 291 311
42. P. Giordano, G.C. Del Vecchio, and N. Santoro Thrombin generation in children with acute lymphoblastic leukemia: effect of leukemia immunophenotypic subgroups Pediatr Hematol Oncol 17 2000 667 672
43. J.M. Journeycake, and G.R. Buchanan Catheter-related deep venous thrombosis and other catheter complications in children with cancer J Clin Oncol 24 2006 4575 4580
44. T.C. Haddad, and E.W. Greeno Chemotherapy-induced thrombosis Thromb Res. 118 2006 555 568
45. J.R. Priest, N.K. Ramsay, and A.J. Bennett The effect of l-asparaginase onantithrombin, plasminogen, and plasma coagulation during therapy for acute lymphoblastic leukemia J Pediatr 100 1982 990 995
46. C. Mauz-Korholz, R. Junker, and U. Gobel Prothrombotic risk factors in children with acute lymphoblastic leukemia treated with delayed E coli asparaginase (COALL-92 and 97 protocols) Thromb Haemost 83 2000 840 843
47. L.G. Mitchell, M. Andrew, and K. Hanna A prospective cohort study determining the prevalence of thrombotic events in children with acute lymphoblastic leukemia and a central venous line who are treated with l-asparaginase: results of the Prophylactic Antithrombin Replacement in Kids with Acute Lymphoblastic Leukemia Treated with Asparaginase (PARKAA) Study Cancer 97 2003 508 516
48. V. Caruso, L. Iacoviello, and A. Di Castelnuovo Thrombotic complications in childhood acute lymphoblastic leukemia: a meta-analysis of 17 prospective studies comprising 1752 pediatric patients Blood 108 2006 2216 2222
49. S. Sallah, J.Y. Wan, and N.P. Nguyen Venous thrombosis in patients with solid tumors: determination of frequency and characteristics Thromb Haemost 87 2002 575 579
50. I. Paz-Priel, L. Long, L.J. Helman, C.L. Mackall, and A.S. Wayne Thromboembolic events in children and young adults with pediatric sarcoma J Clin Oncol 25 2007 1519 1524
51. N. Sameroro, P. Montemurro, P.W. Giordano, F. Schettini, N. Santoro, and D. De Mattia Unbalanced coagulation-fibrinolysis potential during l-asparginase therapy in children with acute lymphoblastic leukemia Thromb Haemost 64 1990 38 40
52. J.R. Priest, N.K. Ramsay, and R.E. Latchaw Thrombotic and hemorrhagic strokes complicating early therapy for childhood acute lymphoblastic leukemia Cancer 46 1980 1548 1554
53. Timoleon Vyzantiadis, Stamatia Theodoridou, Olga Giouleme, Nicolaos Evgenidis, and Athanassios Vyzantiadis Vassilia Garipidou haematologica 87 2002 891 892
54. M. Duval, S. Suciu, and A. Ferster Comparison of Escherichia coli-asparaginase with Erwinia-asparaginase in the treatment of childhood lymphoid malignancies: results of a randomized European Organisation for Research and Treatment of Cancer-Children's Leukemia Group phase 3 trial Blood 99 8 2002 2734 2739
55. U. Nowak-Gottl, E. Ahlke, and G. Fleischhack Thromboembolic events in children with acute lymphoblastic leukemia (BFM protocols): prednisone versus dexamethasone administration Blood 101 2003 2529 2533
56. U. Nowak-Gottl, C. Wermes, and R. Junker Prospective evaluation of the thrombotic risk in children with acute lymphoblastic leukemia carrying the methylenetetrahydrofolate reductase TT 677 genotype, the prothrombin G20210A variant, and further prothrombotic risk factors Blood 93 1999 1595 1599
57. E. Ruud, H. Holmstrom, C. De Lange, and E.M. Hogstad Low-dose warfarin for the prevention of central line-associated thromboses in children with malignancies - a randomized, controlled study Acta Paediatr 95 2006 1053 1059
58. Y. Shoenfeld Systemic antiphospholipid syndrome Lupus 12 2003 497 498
59. S. Miyakis, M.D. Lockshin, and T. Atsumi International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS) J Thromb Haemost 4 2006 295 300
60. T. Avcin, R. Cimaz, and E.D. Silverman Pediatric antiphospholipid syndrome: clinical and immunologic features of 121 patients in an international registry Pediatrics 122 2008 e1100 e1107
61. O. Vaarala, T. Palosuo, and M. Kleemola Anticardiolipin response in acute infections Clin Immunol Immunopathol 41 1986 8 15
62. T. Avčin, A. Ambrozic, and M. Kuhar Anticardiolipin and anti-β2 glycoprotein I antibodies in sera of 61 apparently healthy children at regular preventive visits Rheumatol 40 5 2001 565 573
63. R. Caporali, A. Ravelli, and F. De Gennaro Prevalence of anticardiolipin antibodies in juvenile arthritis Ann Rheum Dis 50 9 1991 599 601
64. D.E. Seaman, V. Londino, and C.K. Kwoh Antiphospholipid antibodies in pediatric systemic lupus erythematosis Pediatrics 96 1995 1040 1045
65. L.B. Tucker Antiphospholipid antibodies and antiphospholipid syndromes in children M.A. Khamashta, Hughes Syndrome, Antiphospholipid Syndrome 2000 Springer London 155 166
66. Z. Uysal, F. Dogu, and A.E. Kurekci Recurrent arterial thrombosis in a child: primary antiphospholipid antibody syndrome Pediatr Hematol Oncol 19 2002 59 66
67. M. Galli, P. Comfurius, and C. Maassen Anticardiolipin antibodies directed not to cardiolipin but to a plasma protein cofactor Lancet 335 1990 1544 1547
68. R. Takeuchi, T. Atsumi, and M. Ieko Suppressed intrinsic fibrinolytic activity by monoclonal anti-beta-2 glycoprotein I autoantibodies: possible mechanism for thrombosis in patients with antiphospholipid syndrome Br J Haematol 119 2002 781
69. T. Koike, M. Bohgaki, and O. Amengual Antiphospholipid antibodies: lessons from the bench J Autoimmun 28 2-3 2007 129 133
70. J. Hanly, and S. Smith Anti-beta2-glycoprotein I (GPI) autoantibodies annexin V binding and the anti-phospholipid syndrome Clin Exp Immunol 120 2000 537
71. G. Kenet, S. Sadetzki, and H. Murad Factor V Leiden and antiphospholipid antibodies are significant risk factors for ischemic stroke in children Stroke 31 2000 1283 1288
72. E. Von Scheven, B. Athreya, and C.D. Rose Clinical characteristics of antiphospholipid antibody syndrome in children J Pediatr 129 3 1996 339 345
73. F. Fischetti, P. Durigutto, and V. Pellis Thrombus formation induced by antibodies to β2-glycoprotein I is complement dependent and requires a priming factor Blood 106 2005 2340 2346
74. S.S. Pierangeli, A.E. Gharavi, and E.N. Harris Experimental thrombosis and antiphospholipid antibodies: new insights J Autoimmun 15 2000 241 247
75. T. Avcin, R. Cimaz, and P.L. Meroni Do we need an international consensus statement on classification criteria for the antiphospholipid syndrome in the paediatric population? Lupus 10 2001 897 898
76. Y. Berkun, S. Padeh, and J. Barash Antiphospholipid syndrome and recurrent thrombosis in children Arthritis Rheum 55 2006 850 855
77. C. Berube, L. Mitchell, and E. Silverman The relationship of antiphospholipid antibodies to thromboembolic events in pediatric patients with systemic lupus erythematosis: a crosssectional study Pediatr Res 44 1998 351 356
78. V. Pengo, A. Biasiolo, P. Rampazzo, and T. Brocco Diluted Russell's viper venom time is more sensitive than KCT or TTI for detecting lupus anticoagulant activity of anti-β2-glycoprotein I antibodies Thromb Haemost 81 1999 256 258
79. O. Amengual, T. Atsumi, and M.A. Khamashta Specificity of ELISA for antibody to beta 2-glycoprotein I in patients with antiphospholipid syndrome Br J Rheumatol 35 12 1996 1239 1243
80. J.I. Malowany, P. Monagle, and D.C. Knoppert Canadian Paediatric Thrombosis and Hemostasis Network. Enoxaparin for neonatal thrombosis: a call for a higher dose for neonates Thromb Res 122 6 2008 826 830
81. E. Somers, L.S. Magder, and M. Petri Antiphospholipid antibodies and incidence of venous thrombosis in a cohort of patients with systemic lupus erythematosus J Rheumatol 29 12 2002 2531
82. D. Alarcón-Segovia, M.C. Boffa, and W. Branch Prophylaxis of the antiphospholipid syndrome: a consensus report Lupus 12 7 2003 499
83. M. Sharma, and S. Carpenter Thromboprophylaxis in a pediatric hospital Curr Prob Pediatr Adolesc Health Care 43 2013 177 182